Pages that link to "Q41823653"
Jump to navigation
Jump to search
The following pages link to Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier. (Q41823653):
Displaying 16 items.
- Central Neurotoxicity in Cancer Chemotherapy: Pharmacogenetic inSights (Q33857581) (← links)
- Reproducibility of quantitative (R)-[11C]verapamil studies (Q35742284) (← links)
- Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes (Q35768413) (← links)
- Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo (Q35996706) (← links)
- A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier (Q36386154) (← links)
- Advances in PET imaging of P-glycoprotein function at the blood-brain barrier (Q36638627) (← links)
- PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo (Q36953090) (← links)
- A novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood-brain barrier (Q36955931) (← links)
- Carbon-11 N-methyl alkylation of L-368,899 and in vivo PET imaging investigations for neural oxytocin receptors (Q37130157) (← links)
- The controversial role of ABC transporters in clinical oncology. (Q37941758) (← links)
- P-glycoprotein imaging in temporal lobe epilepsy: in vivo PET experiments with the Pgp substrate [11C]-verapamil (Q38058376) (← links)
- Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy. (Q38420352) (← links)
- The possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy (Q38633232) (← links)
- P-Glycoprotein Altered Expression in Alzheimer's Disease: Regional Anatomic Variability (Q40597133) (← links)
- In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy (Q48294616) (← links)
- [MUV researcher of the month, March 2015]. (Q52710136) (← links)